Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
9.13B
Market cap9.13B
Price-Earnings ratio
25.93
Price-Earnings ratio25.93
Dividend yield
—
Dividend yield—
Average volume
1.60M
Average volume1.60M
High today
$132.53
High today$132.53
Low today
$128.01
Low today$128.01
Open price
$132.31
Open price$132.31
Volume
2.90M
Volume2.90M
52 Week high
$354.88
52 Week high$354.88
52 Week low
$126.40
52 Week low$126.40

Stock Snapshot

As of today, Insulet(PODD) shares are valued at $131.69. The company's market cap stands at 9.13B, with a P/E ratio of 25.93.

During the trading session on 2026-10-02, Insulet(PODD) shares reached a daily high of $132.53 and a low of $128.01. At a current price of $131.69, the stock is +2.9% higher than the low and still -0.6% under the high.

Trading activity shows a volume of 2.9M, compared to an average daily volume of 1.6M.

The stock's 52-week range extends from a low of $126.40 to a high of $354.88.

The stock's 52-week range extends from a low of $126.40 to a high of $354.88.

PODD News

MarketWatch 2d
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch

...

Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
Simply Wall St 7d
Insulet Could Be 27% Undervalued On Its Debt Refinancing Reset

Insulet (PODD) has just reworked its lending arrangements, replacing US$475m of term loans with new debt at lower interest margins and expanding its undrawn rev...

Insulet Could Be 27% Undervalued On Its Debt Refinancing Reset

Analyst ratings

57%

of 28 ratings
Buy
57.1%
Hold
42.9%
Sell
0%

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.